Absence of Seroconversion to Hepatitis B and C among Blood Donors with Elevated Alanine Aminotransferase
暂无分享,去创建一个
[1] S. Kleinman,et al. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study , 1995, Transfusion.
[2] W. H. Hall,et al. Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. , 1995, JAMA.
[3] W. H. Hall,et al. Infectious disease testing for blood transfusions. , 1995, NIH consensus statement.
[4] A. Albertini,et al. Long‐term follow‐up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels , 1995, Transfusion.
[5] G. Vyas,et al. Rare detection of hepatitis B and hepatitis C virus genomes by polymerase chain reaction in seronegative donors with elevated alanine aminotransferase , 1994, Transfusion.
[6] R. Kahn,et al. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: the transfusion-transmitted viruses study. , 1981, The New England journal of medicine.